The Cooper Companies, Inc. $COO Stock Position Raised by Teacher Retirement System of Texas

Teacher Retirement System of Texas lifted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 4.1% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 30,366 shares of the medical device company’s stock after acquiring an additional 1,191 shares during the quarter. Teacher Retirement System of Texas’ holdings in Cooper Companies were worth $2,161,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in COO. Goldman Sachs Group Inc. lifted its position in shares of Cooper Companies by 17.0% in the 1st quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company’s stock valued at $399,340,000 after acquiring an additional 686,751 shares in the last quarter. Millennium Management LLC lifted its position in shares of Cooper Companies by 36.0% in the 1st quarter. Millennium Management LLC now owns 2,577,416 shares of the medical device company’s stock valued at $217,405,000 after acquiring an additional 682,166 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Cooper Companies in the 1st quarter valued at approximately $55,367,000. Alecta Tjanstepension Omsesidigt lifted its position in Cooper Companies by 60.7% in the 2nd quarter. Alecta Tjanstepension Omsesidigt now owns 1,349,500 shares of the medical device company’s stock worth $96,030,000 after buying an additional 509,800 shares in the last quarter. Finally, Select Equity Group L.P. lifted its position in Cooper Companies by 185.0% in the 1st quarter. Select Equity Group L.P. now owns 749,050 shares of the medical device company’s stock worth $63,182,000 after buying an additional 486,241 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Brian G. Andrews bought 1,525 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The shares were acquired at an average cost of $65.68 per share, for a total transaction of $100,162.00. Following the purchase, the executive vice president owned 22,191 shares of the company’s stock, valued at $1,457,504.88. This represents a 7.38% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Albert G. White III bought 10,000 shares of the stock in a transaction that occurred on Friday, September 5th. The stock was purchased at an average price of $68.39 per share, for a total transaction of $683,900.00. Following the completion of the purchase, the chief executive officer directly owned 226,151 shares in the company, valued at $15,466,466.89. The trade was a 4.63% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 17,975 shares of company stock worth $1,216,346 in the last ninety days. 1.98% of the stock is owned by insiders.

Cooper Companies Stock Performance

Shares of COO opened at $69.82 on Tuesday. The company’s fifty day moving average is $69.30 and its 200-day moving average is $72.88. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $107.84. The firm has a market cap of $13.88 billion, a price-to-earnings ratio of 34.39, a price-to-earnings-growth ratio of 1.83 and a beta of 1.02. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter in the prior year, the business posted $0.96 EPS. Cooper Companies’s quarterly revenue was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies declared that its board has initiated a share repurchase plan on Wednesday, September 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the medical device company to repurchase up to 15.4% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company’s management believes its stock is undervalued.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on COO shares. The Goldman Sachs Group set a $64.00 target price on shares of Cooper Companies and gave the stock a “sell” rating in a research report on Wednesday, October 1st. BNP Paribas Exane upgraded shares of Cooper Companies from a “neutral” rating to an “outperform” rating and set a $92.00 target price for the company in a research report on Tuesday, July 22nd. Morgan Stanley set a $76.00 target price on shares of Cooper Companies and gave the stock an “equal weight” rating in a research report on Thursday, August 28th. Needham & Company LLC reiterated a “buy” rating and issued a $94.00 target price on shares of Cooper Companies in a research report on Thursday, August 28th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Cooper Companies in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Cooper Companies has an average rating of “Moderate Buy” and an average target price of $84.77.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.